Staging of cutaneous melanoma

Annals of Oncology

Volumn 20, Issue SUPPL. 4, 2009, Pages

  Mohr, P ^a   Eggermont, A M M ^b   Hauschild, A ^c   Buzaid, A ^d  

^a Buxtehude   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF KIEL   (Germany)

^d HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Follow up; Imaging; Melanoma; Staging system; Staging work up

Indexed keywords

CANCER STAGING; DIAGNOSTIC IMAGING; HUMAN; MELANOMA; PATHOLOGY; REVIEW; SKIN TUMOR;

DIAGNOSTIC IMAGING; HUMANS; MELANOMA; NEOPLASM STAGING; SKIN NEOPLASMS;

EID: 79960362581     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp256     Document Type: Article

References (60)

1. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Natl Compr Canc Netw 2006; 4: 666-684.
2. Garbe C, Hauschild A, Volkenandt M et al. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res 2007; 17: 393-399.
3. Dummer R, Panizzon R, Bloch PH, Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology 2005; 210: 39-44.
4. Davis SD. CT evaluation for pulmonary metastases in patients with extrathoracic malignancy. Radiology 1991; 180: 1-12.
5. Heaston DK, Putman CE, Rodan BA et al. Solitary pulmonary metastases in highrisk melanoma patients: a prospective comparison of conventional and computed tomography. AJR Am J Roentgenol 1983; 141: 169-174.
6. Kostrubiak I, Whitley NO, Aisner J et al. The use of computed body tomography in malignant melanoma. JAMA 1988; 259: 2896-2897.
7. Daldrup-Link HE, Franzius C, Link TM et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001; 177: 229-236.
8. Kaufmann PM, Crone-Munzebrock W. Tumor follow-up using sonography and computed tomography in the abdominal region of patients with malignant melanoma. Aktuelle Radiol 1992; 2: 81-85.
9. Ferrucci JT. Liver tumor imaging: current concepts. AJR Am J Roentgenol 1990; 155: 473-484.
10. Paley MR, Ros PR. Hepatic metastases. Radiol Clin North Am 1998; 36: 349-363.
11. Ghanem N, Altehoefer C, Hogerle S et al. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol 2005; 54: 264-270.
12. Yock DH. Magnetic Resonance Imaging of CNS. Mosby Yearbook 1995.
13. Cerfolio RJ, Ojha B, Bryant AS et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004; 78: 1017-1023.
14. Halpern BS, Schiepers C, Weber WA et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005; 128: 2289-2297.
15. Lardinois D, Weder W, Hany TF et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-2507.
16. Reinhardt MJ, Joe AY, Jaeger U et al. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 2006; 24: 1178-1187.
17. Holder Jr, WD White Jr, RL Zuger JH et al. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998; 227: 764-769.
18. Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993; 34: 1420-1427.
19. Paquet P, Hustinx R, Rigo P, Pierard GE. Malignant melanoma staging using whole-body positron emission tomography. Melanoma Res 1998; 8: 59-62.
20. Rinne D, Baum RP, Hor G, Kaufmann R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer 1998; 82: 1664-1671.
21. Steinert HC, Huch Boni RA, Buck A et al. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-Dglucose. Radiology 1995; 195: 705-709.
22. Swetter SM, Carroll LA, Johnson DL, Segall GM. Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Ann Surg Oncol 2002; 9: 646-653.
23. Tyler DS, Onaitis M, Kherani A et al. Positron emission tomography scanning in malignant melanoma. Cancer 2000; 89: 1019-1025.
24. Aydin A, Yu JQ, Zhuang H, Alavi A. Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma. Clin Nucl Med 2005; 30: 606-607.
25. Kuvshinoff BW, Kurtz C, Coit DG. Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol 1997; 4: 252-258.
26. Iagaru A, Quon A, Johnson D et al. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol 2007; 9: 50-57.
27. Balch CM, Soong SJ, Shaw H et al. An analysis of prognostic factors in 4000 patients with cutaneous melanoma. In Balch C, Milton G (eds): Cutaneous Melanoma. Philadelphia: JB Lippincott 1985; pp. 321.
28. Buzaid AC, Sandler AB, Mani S et al. Role of computed tomography in the staging of primary melanoma. J Clin Oncol 1993; 11: 638-643.
29. Rossi CR, Mocellin S, Scagnet B et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 2003; 83: 80-84.
30. Voit CA, van Akkooi AC, Schä fer-Hesterberg G et al. Role of ultrasound (US) and US-guided fine needle aspiration cytology (US-FNAC) prior to sentinel lymph node biopsy (SLNB) in 500 melanoma patients: reduction of need for SNLB by high US-FNAC SN positive identification rate. 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007: 25 Abstr 8512.
31. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-466.
32. Dufresne EN, Kaplan WD, Zimmerman RE, Rose CM. The application of internal mammary lymphoscintigraphy to planning of radiation therapy. J Nucl Med 1980; 21: 697-699.
33. Jones D, Hanelin L, Christopherson D et al. Radiotherapy treatment planning using lymphoscintigraphy. Int J Radiat Oncol Biol Phys 1986; 12: 1707-1710.
34. Siddon RL, Chin LM, Zimmerman RE et al. Utilization of parasternal lymphoscintigraphy in radiation therapy of breast carcinoma. Int J Radiat Oncol Biol Phys 1982; 8: 1059-1063.
35. Campisi C, Boccardo F. Role of microsurgery in the management of lymphoedema. Int Angiol 1999; 18: 47-51.
36. Gannon CJ, Rousseau Jr, DL. Ross MI et al. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Cancer 2006; 107: 2647-2652.
37. Uren RF, Howman-Giles RB, Shaw HM et al. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993; 34: 1435-1440.
38. Patten RM, Shuman WP, Teefey S. Subcutaneous metastases from malignant melanoma: prevalence and findings on CT. AJR Am J Roentgenol 1989; 152: 1009-1012.
39. Patten RM, Shuman WP, Teefey S. Metastases from malignant melanoma to the axial skeleton: a CT study of frequency and appearance. AJR Am J Roentgenol 1990; 155: 109-112.
40. Fon GT, Wong WS, Gold RH, Kaiser LR. Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review. AJR Am J Roentgenol 1981; 137: 103-108.
41. Finck SJ, Giuliano AE, Morton DL. LDH and melanoma. Cancer 1983; 51: 840-843.
42. Buer J, Probst M, Franzke A et al. Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer 1997; 75: 1373-1376.
43. Hauschild A, Michaelsen J, Brenner W et al. Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Res 1999; 9: 155-161.
44. Banfalvi T, Boldizsar M, Gergye M et al. Comparison of prognostic significance of serum 5-S-cysteinyldopa, LDH and S-100B protein in stage III-IV malignant melanoma. Pathol Oncol Res 2002; 8: 183-187.
45. Haffner AC, Garbe C, Burg G et al. The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer 1992; 66: 856-861.
46. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978; 135: 807-810.
47. Aloia TA, Gershenwald JE, Andtbacka RH et al. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol 2006; 24: 2858-2865.
48. Blum A, Schlagenhauff B, Stroebel W et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer 2000; 88: 2534-2539.
49. Bastiaannet E, Oyen WJ, Meijer S et al. Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. Br J Surg 2006; 93: 243-249.
50. Wagner JD, Schauwecker D, Davidson D et al. Inefficacy of F-18 fluorodeoxy-Dglucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer 2005; 104: 570-579.
51. Fink AM, Holle-Robatsch S, Herzog N et al. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res 2004; 14: 141-145.
52. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005; 46: 752-757.
53. Miranda EP, Gertner M, Wall J et al. Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease. Arch Surg 2004; 139: 831-837.
54. Gold JS, Jaques DP, Busam KJ et al. Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy. Ann Surg Oncol 2007; 14: 2133-2140.
55. Buzaid AC, Ross MI, Balch CM et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997; 15: 1039-1051.
56. Shirkhoda A, Albin J. Malignant melanoma: correlating abdominal and pelvic CT with clinical staging. Radiology 1987; 165: 75-78.
57. Buzaid AC, Tinoco L, Ross MI et al. Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol 1995; 13: 2104-2108.
58. Johnson TM, Fader DJ, Chang AE et al. Computed tomography in staging of patients with melanoma metastatic to the regional nodes. Ann Surg Oncol 1997; 4: 396-402.
59. Choi EA, Gershenwald JE. Imaging studies in patients with melanoma. Surg Oncol Clin N Am 2007; 16: 403-430.
60. Damian DL, Fulham MJ, Thompson E, Thompson JF. Positron emission tomography in the detection and management of metastatic melanoma. Melanoma Res 1996; 6: 325-329.